Young-Whan Park – President, National OncoVenture, South Korea

Young-Whan Park, president of National OncoVenture, discusses their programme to support oncology drug development in South Korea, with a view to discovering and producing a globally competitive, Korean-made oncology medicine. Dr Park also provides his assessment of Korea’s challenge in commercialising its academic research.  
NOV not only supports research financially but also co-develops the chosen oncology drug candidate in collaboration with the originator. This differentiates us from other government R&D support initiatives which are fund supporting programs
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report